Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
18998 | 527 | 38.1 | 85% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
159 | 3 | MENOPAUSE//ISOFLAVONES//TAMOXIFEN | 61134 |
1407 | 2 | 2 METHOXYESTRADIOL//STEROID SULFATASE//17 BETA HYDROXYSTEROID DEHYDROGENASE | 8029 |
18998 | 1 | 2 METHOXYESTRADIOL//2 METHOXYOESTRADIOL//2 METHOXYESTRADIOL BIS SULPHAMATE | 527 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | 2 METHOXYESTRADIOL | authKW | 7869036 | 35% | 73% | 185 |
2 | 2 METHOXYOESTRADIOL | authKW | 500769 | 2% | 79% | 11 |
3 | 2 METHOXYESTRADIOL BIS SULPHAMATE | authKW | 347644 | 1% | 100% | 6 |
4 | STERIX LTD | address | 340661 | 4% | 28% | 21 |
5 | 2 METHOXYESTRADIOL 2ME2 | authKW | 297979 | 1% | 86% | 6 |
6 | MED CHEM STERIX LTD | address | 283905 | 1% | 70% | 7 |
7 | ENDOCRINOL METAB MED STERIX LTD | address | 276062 | 2% | 53% | 9 |
8 | 2 METHOXYESTRADIOL ANALOGS | authKW | 231763 | 1% | 100% | 4 |
9 | ESE 16 | authKW | 231763 | 1% | 100% | 4 |
10 | 2 ETHYL 3 O SULPHAMOYL ESTRA 1 3 51016 TETRAENE | authKW | 173822 | 1% | 100% | 3 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 1703 | 30% | 0% | 160 |
2 | Endocrinology & Metabolism | 487 | 13% | 0% | 67 |
3 | Chemistry, Medicinal | 355 | 8% | 0% | 44 |
4 | Biochemistry & Molecular Biology | 220 | 21% | 0% | 109 |
5 | Pharmacology & Pharmacy | 192 | 13% | 0% | 71 |
6 | Cell Biology | 121 | 10% | 0% | 51 |
7 | Reproductive Biology | 86 | 3% | 0% | 15 |
8 | Medicine, Research & Experimental | 85 | 6% | 0% | 31 |
9 | Peripheral Vascular Diseases | 64 | 4% | 0% | 21 |
10 | Obstetrics & Gynecology | 51 | 4% | 0% | 20 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | STERIX LTD | 340661 | 4% | 28% | 21 |
2 | MED CHEM STERIX LTD | 283905 | 1% | 70% | 7 |
3 | ENDOCRINOL METAB MED STERIX LTD | 276062 | 2% | 53% | 9 |
4 | PHARM PHARMACOL STERIX LTD | 130365 | 1% | 75% | 3 |
5 | CELLULAR DIFFERENTIAT TRANSFORMAT | 115881 | 0% | 100% | 2 |
6 | SCEENING TECHNOL BRANCH | 115881 | 0% | 100% | 2 |
7 | ONCOL DRUG DISCOVERY WOMENS HLTH GRP | 92700 | 1% | 40% | 4 |
8 | SECT ENDOCRINOL MENOPAUSE | 67586 | 1% | 17% | 7 |
9 | ABBOTT PROD GMBH | 57941 | 0% | 100% | 1 |
10 | ALBERT BONNIOT CRIINSERMUJFU823 | 57941 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | STEROIDS | 3840 | 3% | 0% | 17 |
2 | CANCER CELL INTERNATIONAL | 1881 | 1% | 1% | 5 |
3 | JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY | 1835 | 3% | 0% | 17 |
4 | MOLECULAR CANCER THERAPEUTICS | 1409 | 2% | 0% | 10 |
5 | BIOCELL | 1113 | 1% | 1% | 3 |
6 | CELL BIOCHEMISTRY AND FUNCTION | 1072 | 1% | 0% | 6 |
7 | REPRODUCTIVE SCIENCES | 1025 | 1% | 0% | 5 |
8 | HYPERTENSION | 968 | 3% | 0% | 14 |
9 | VASCULAR PHARMACOLOGY | 814 | 1% | 0% | 4 |
10 | BIOMEDICAL RESEARCH-INDIA | 751 | 1% | 0% | 4 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | KUMAR, BS , RAGHUVANSHI, DS , HASANAIN, M , ALAM, S , SARKAR, J , MITRA, K , KHAN, F , NEGI, AS , (2016) RECENT ADVANCES IN CHEMISTRY AND PHARMACOLOGY OF 2-METHOXYESTRADIOL: AN ANTICANCER INVESTIGATIONAL DRUG.STEROIDS. VOL. 110. ISSUE . P. 9 -34 | 118 | 68% | 2 |
2 | PEYRAT, JF , BRION, JD , ALAMI, M , (2012) SYNTHETIC 2-METHOXYESTRADIOL DERIVATIVES: STRUCTURE-ACTIVITY RELATIONSHIPS.CURRENT MEDICINAL CHEMISTRY. VOL. 19. ISSUE 24. P. 4142-4156 | 109 | 83% | 15 |
3 | SOLUM, EJ , AKSELSEN, OW , VIK, A , HANSEN, TV , (2015) SYNTHESIS AND PHARMACOLOGICAL EFFECTS OF THE ANTI-CANCER AGENT 2-METHOXYESTRADIOL.CURRENT PHARMACEUTICAL DESIGN. VOL. 21. ISSUE 38. P. 5453 -5466 | 59 | 86% | 0 |
4 | MUECK, AO , SEEGER, H , (2010) 2-METHOXYESTRADIOL-BIOLOGY AND MECHANISM OF ACTION.STEROIDS. VOL. 75. ISSUE 10. P. 625-631 | 56 | 74% | 82 |
5 | PINTO, MP , MEDINA, RA , OWEN, GI , (2014) 2-METHOXYESTRADIOL AND DISORDERS OF FEMALE REPRODUCTIVE TISSUES.HORMONES & CANCER. VOL. 5. ISSUE 5. P. 274 -283 | 57 | 64% | 4 |
6 | GORSKA, M , KUBAN-JANKOWSKA, A , SLAWEK, J , WOZNIAK, M , (2016) NEW INSIGHT INTO 2-METHOXYESTRADIOL- A POSSIBLE PHYSIOLOGICAL LINK BETWEEN NEURODEGENERATION AND CANCER CELL DEATH.CURRENT MEDICINAL CHEMISTRY. VOL. 23. ISSUE 15. P. 1513 -1527 | 67 | 53% | 0 |
7 | PARKS, M , TILLHON, M , DONA, F , PROSPERI, E , SCOVASSI, AI , (2011) 2-METHOXYESTRADIOL: NEW PERSPECTIVES IN COLON CARCINOMA TREATMENT.MOLECULAR AND CELLULAR ENDOCRINOLOGY. VOL. 331. ISSUE 1. P. 119-128 | 47 | 75% | 9 |
8 | PARADA-BUSTAMANTE, A , VALENCIA, C , REUQUEN, P , DIAZ, P , RINCON-RODRIGUEZ, R , ORIHUELA, PA , (2015) ROLE OF 2-METHOXYESTRADIOL, AN ENDOGENOUS ESTROGEN METABOLITE, IN HEALTH AND DISEASE.MINI-REVIEWS IN MEDICINAL CHEMISTRY. VOL. 15. ISSUE 5. P. 427 -438 | 66 | 45% | 4 |
9 | SUTHERLAND, TE , ANDERSON, RL , HUGHES, RA , ALTMANN, E , SCHULIGA, M , ZIOGAS, J , STEWART, AG , (2007) 2-METHOXYESTRADIOL - A UNIQUE BLEND OF ACTIVITIES GENERATING A NEW CLASS OF ANTI-TUMOUR/ANTI-INFLAMMATORY AGENTS.DRUG DISCOVERY TODAY. VOL. 12. ISSUE 13-14. P. 577-584 | 40 | 74% | 56 |
10 | MARAIS, S , MQOCO, T , STANDER, A , VAN PAPENDORP, D , JOUBERT, A , (2012) THE IN VITRO EFFECTS OF A SULPHAMOYLATED DERIVATIVE OF 2-METHOXYESTRADIOL ON CELL NUMBER, MORPHOLOGY AND ALPHA-TUBULIN DISRUPTION IN CERVICAL ADENOCARCINOMA (HELA) CELLS.BIOMEDICAL RESEARCH-INDIA. VOL. 23. ISSUE 3. P. 357-362 | 29 | 85% | 4 |
Classes with closest relation at Level 1 |